Evidence map›Paper›PMID 40204874›Full record

ArticleScientific reports2025

Optimizing the compliance third-party supervision workflow of involved enterprises using artificial intelligence ant colony algorithm.

Danqi Chen, Weichen Jia, Qi Chen, Jianing Chen, Zhi Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danqi ChenSchool of Media and Law, NingboTech University, Ningbo, 315000, China.
Weichen JiaSchool of Media and Law, NingboTech University, Ningbo, 315000, China.
Qi ChenSchool of Media and Law, NingboTech University, Ningbo, 315000, China.
Jianing ChenSchool of Media and Law, NingboTech University, Ningbo, 315000, China.
Zhi LiSchool of Media and Law, NingboTech University, Ningbo, 315000, China. lizhi@nbt.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article optimized the compliance third-party supervision workflow of the involved enterprises based on the artificial intelligence ant colony optimization (ACO) algorithm. The basic principles and application advantages of ACO were introduced, and a heuristic information matrix was defined using ACO to optimize the data collection and analysis stage of the compliance third-party supervision workflow. During the experimental phase, a feasibility analysis was conducted on the optimization of third-party supervision workflows for compliance by ACO involved enterprises through simulation experiments. The experiments were evaluated from four aspects: data quality, model performance, scheme effectiveness, and supervision effectiveness. Among the metrics data for the ACO-optimized test set were 0.03 and 0.025 for MSE (Mean Square Error) and Γ, 0.8, 0.78, 0.79, and 0.88 for Accuracy, Recall, F1 Score, and AUC-ROC (Area Under the Curve-Receiver Operating Characteristic), and 0.28, 0.4, 0.88, and 0.12 for CER (Cost-Effectiveness Ratio), NPV (Net Present Value), SCR (Supervision Coverage Rate), and CRC (Compliance Rate Change), respectively. The experimental results showed that, in terms of data quality, model performance, scheme effectiveness, and supervision effectiveness, the evaluation indicators of the compliance third-party supervision workflow of the involved enterprises optimized using ACO were superior to those without ACO optimization.

Indexed as

Algorithm optimizationAnt colony optimizationArtificial intelligenceInvolved enterprisesThird-party supervision

Identifiers

PMID40204874
PMCPMC11982365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.